A Phase 2 GFR Measuring Study of RTA 402 in CKD Patients With Type 2 Diabetes Mellitus.
Phase of Trial: Phase II
Latest Information Update: 06 Mar 2017
At a glance
- Drugs Bardoxolone methyl (Primary)
- Indications Diabetic nephropathies
- Focus Adverse reactions; Therapeutic Use
- Sponsors Kyowa Hakko Kirin
- 11 Nov 2013 Status changed from suspended to discontinued, as reported in a Kyowa Hakko Kirin media release.
- 19 Oct 2012 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 16 Apr 2012 New trial record